We will soon be able to deliver the vaccine doses to the world that we have promised to deliver.

The American company Pfizer has announced that it will soon be able to provide the world with the doses of vaccine it has promised to deliver.

Pfizer had earlier announced that it was working to deliver two billion doses of an emerging corona virus (Covid-19) vaccine during the current year, before announcing a disruption in shipping dates for short-term vaccines, and that vaccine delivery shipments she developed would be affected between late January and early February.

However, he confirmed that he would provide a significant dose increase to patients between February and March.

Pfizer will be able to deliver 200 million doses of the Covid-19 vaccine to the United States by the end of May, two months ahead of schedule, according to its chief executive.

CEO Albert Burla said last Tuesday that the pharmaceutical company and its partner, BioNTech, would be able to deliver the doses to the United States before the July 31 deadline.

The number of six doses per vial went into effect Monday and applies to future supply contracts, according to a representative from Pfizer.

In the United States, Pfizer and BioNTech will deliver 120 million doses in the first quarter, 20 million more than they initially promised, Burla said in an interview with Bloomberg.

This comes after the European Union Medicines Agency confirmed today, Friday, that the Pfizer / Biontech vaccine is not linked to the deaths recorded among people who received it and that it does not cause no new side effects, based on early data related to its launch.

The agency said it had seen the recorded deaths, including those in a number of elderly people, and “concluded that the data did not show a relationship with the order to receive the Pfizer vaccine and that the cases do not raise any safety concerns. “

Yesterday, Pfizer and Biontec announced that their vaccine against the “Covid-19” epidemic preserves most of its effectiveness against the two major mutations of the emerging corona virus, the British and South Africa.

The statement said laboratory tests “do not indicate the need for a new vaccine to deal with emerging variants.”